Charlie Yang is a Vice President in Equity Research on the US Biopharmaceuticals team, covering Large/SMid Cap Biotech and Major Pharma. Prior to joining BofA, Yang was an Equity Research Senior Associate at Morgan Stanley, covering Major Pharma and Large/SMid Cap Biotech. Before that, he was a strategic project manager at GLG. He has a PhD in Anatomy and Neurobiology from Boston University School of Medicine and a BS from the University of California, Irvine.